Interestingly, many studies have suggested that some mutations in TREM2 (triggering receptor expressed on myeloid cells 2) correlate with a significantly increased risk of developing AD [33,34], leading to a substantial risk of developing AD in their mid-60s [35]. The gene discussed is TREM2; the disease is Alzheimer disease.